These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3670703)

  • 41. Estrogen receptors, antibodies and hormone dependent cancer.
    DeSombre ER; Greene GL; King WJ; Jensen EV
    Prog Clin Biol Res; 1984; 142():1-21. PubMed ID: 6538684
    [No Abstract]   [Full Text] [Related]  

  • 42. [Detection of steroid hormone receptors in patients with mastopathies and fibroadenomas].
    Meissner J; Kasch R; Splitt G; Gerber B; Rhode E
    Zentralbl Gynakol; 1989; 111(23):1562-6. PubMed ID: 2624008
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Screening and detection of breast cancer and prostate cancer.
    Saloustros E; Mavroudis D
    JAMA; 2010 Mar; 303(11):1032; author reply 1033-4. PubMed ID: 20233817
    [No Abstract]   [Full Text] [Related]  

  • 44. [Immunohistochemical detection of estrogen and progesterone receptors in paraffin sections].
    Snijders M; Theunissen P; Debets-Te Baerts M; Koudstaal J
    Pathologe; 1990 Jul; 11(4):236-9. PubMed ID: 2204912
    [No Abstract]   [Full Text] [Related]  

  • 45. [Hormone receptors in cancerology of the breast. Where do we stand in 1987?].
    Van Cauwenberge JR; Duvivier J; Hustin J; Lambotte R
    Rev Med Liege; 1987 Sep; 42(18):733-6. PubMed ID: 3317694
    [No Abstract]   [Full Text] [Related]  

  • 46. Prognostic value of estrogen receptor determinations in patients with breast cancer.
    Rich MA; Furmanski P; Brooks SC
    Cancer Res; 1978 Nov; 38(11 Pt 2):4296-8. PubMed ID: 698969
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Re: Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population.
    Caan B; Habel L; Quesenberry C; Kushi L; Herrinton L
    J Natl Cancer Inst; 2008 Apr; 100(8):597-8; author reply 599. PubMed ID: 18398101
    [No Abstract]   [Full Text] [Related]  

  • 48. [Estrogen receptors and clinical prognostic factors in breast cancer].
    Hernández JL; Lera JM; Fakih A; Gómez Portilla A; Vicente F; Zornoza G
    Rev Esp Oncol; 1983; 30(2):179-88. PubMed ID: 6097962
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Hormonal receptors and breast cancer. Review of the literature and personal experience].
    Gallo A; Baldi F; Giannantoni C; Dell'Agli P; Caselli G
    Minerva Chir; 1988 Mar; 43(5):429-32. PubMed ID: 2840607
    [No Abstract]   [Full Text] [Related]  

  • 50. Hormone receptors in breast cancer.
    Fortuny IE; Bates HA
    Minn Med; 1981 Dec; 64(12):761-3. PubMed ID: 6278280
    [No Abstract]   [Full Text] [Related]  

  • 51. Association of estrogen receptors with parenchymal pattern at mammography.
    Ciatto S; Cecchini S; Iossa A; Grazzini G; Messeri G; Valenti L; Nunzi G; Bartolucci R; Di Costanzo F
    Radiology; 1989 Mar; 170(3 Pt 1):695-7. PubMed ID: 2916023
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Hormone receptors in breast cancer. History and perspectives].
    Milgrom E
    Pathol Biol (Paris); 1983 Nov; 31(9):721-2. PubMed ID: 6361669
    [No Abstract]   [Full Text] [Related]  

  • 53. [Clinical-biological meaning of progesterone receptor status in 118 estrogen receptor positive infiltrating ductal carcinomas of the breast in post-menopausal women].
    Ruibal A; Schneider J; Arias J; del Río MC; Núnez MJ; Tejerina A
    Rev Esp Med Nucl; 2000 Jun; 19(3):244-6. PubMed ID: 11062090
    [No Abstract]   [Full Text] [Related]  

  • 54. Hormone receptor assessment for endocrine therapy in advanced breast cancer. Report of 28 cases.
    Chen PZ; Mei ZJ; Yao XY; Meng XQ
    Chin Med J (Engl); 1983 Oct; 96(10):751-3. PubMed ID: 6426873
    [No Abstract]   [Full Text] [Related]  

  • 55. [Estrogen and progesterone receptors in carcinoma of the breast].
    Musiani P; Piantelli M; Dina MA
    Pathologica; 1979; 71(1011):1-7. PubMed ID: 450473
    [No Abstract]   [Full Text] [Related]  

  • 56. [Radioactive labeling of cytoplasmic hormone receptors. Determination and clinical significance of estrogen and progesterone receptors].
    Spona J
    Fortschr Med; 1984 Sep; 102(35):856-8. PubMed ID: 6489891
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Steroid receptors in cystosarcoma phyllodes.
    Brentani MM; Nagai MA; Oshima CT; Pacheco MM; Góes JC; Lemos LB
    Cancer Detect Prev; 1982; 5(2):211-9. PubMed ID: 6290062
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Correlation between histological parameters and receptor status of tumors of the breast: analysis of a homogeneous population from Mantua].
    Dina R; Bellomi A
    Pathologica; 1987; 79(1059-1060):91-6. PubMed ID: 3441415
    [No Abstract]   [Full Text] [Related]  

  • 59. [Correlation of histopathologic and immunohistochemical data (using the D5 antibody) and biochemical analysis in the study of estrogen receptors in breast carcinoma].
    Bussolati G; Pietribiasi F; Gugliotta P; Conti G; Di Carlo F
    Pathologica; 1987; 79(1059-1060):45-50. PubMed ID: 3441410
    [No Abstract]   [Full Text] [Related]  

  • 60. [Receptor status and ovarian function in carcinoma of the breast].
    Giuffrida D; La Porta GA; Sicurella C; La Rosa GL; Milazzo G; Foti E; Marchese V; Lanza C; Vigneri R; Belfiore A
    G Ital Oncol; 1989; 9(2-3):73-6. PubMed ID: 2767731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.